ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Ann Arbor, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Dermatitis
Atopic Dermatitis
Skin Diseases
Food Hypersensitivity
Hypersensitivity
Pruritus
Psoriasis

Eczema trials near Ann Arbor, MI, USA:

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy (ADHAND)

The purpose of this study is to test if treatment with tralokinumab is safe and effectful to treat moderate-to-severe atopic hand eczema. Th...

Enrolling
Atopic Hand Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Tralokinumab

Phase 3

LEO Pharma
LEO Pharma

Detroit, Michigan, United States and 75 other locations

This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety...

Active, not recruiting
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Placebo
Drug: Camoteskimab

Phase 2

Apollo Therapeutics

Waterford, Michigan, United States of America and 35 other locations

the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...

Active, not recruiting
Atopic Dermatitis
Biological: Placebo
Biological: OpSCF

Phase 2

Opsidio

Auburn Hills, Michigan, United States and 21 other locations

Status recently updated

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

Not yet enrolling
Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: GHZ339

Phase 2

Novartis
Novartis

Troy, Michigan, United States and 10 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Enrolling
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Auburn Hills, Michigan, United States and 19 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

Troy, Michigan, United States and 26 other locations

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

Phase 3

AbbVie
AbbVie

Detroit, Michigan, United States and 179 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Enrolling
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Ypsilanti, Michigan, United States and 86 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Ypsilanti, Michigan, United States and 83 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07264660
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Troy, Michigan, United States of America and 72 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems